Identifying early signs of ADHD and autism in infants
Infant Predictors of ADHD and ASD Symptomology
This study is looking at how we can spot early signs of ADHD and Autism in babies by watching how they communicate, pay attention, and move, so we can help kids who might be at risk as they grow up.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10906669 on NIH RePORTER |
What this research studies
This research investigates how early signs of Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD) can be identified in infants. By observing social communication, attention, and motor skills in infants with varying genetic risks for these disorders, the study aims to understand the unique characteristics that may predict later development of ADHD and ASD. The approach involves a longitudinal design, tracking these infants over time to gather comprehensive data that could lead to better screening and intervention strategies. This research is crucial for developing tailored approaches to support children at risk.
Who could benefit from this research
Good fit: Ideal candidates for this research include infants under 3 years old who have a family history of ADHD or ASD, as well as those with no such history.
Not a fit: Patients who are older than 3 years or do not have a family history of ADHD or ASD may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate identification of children at risk for ADHD and ASD, allowing for timely interventions that improve outcomes.
How similar studies have performed: Previous research has shown promise in identifying early predictors of ADHD and ASD, suggesting that this approach could yield valuable insights.
Where this research is happening
Columbia, United States
- University of South Carolina at Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Federico, Alexis — University of South Carolina at Columbia
- Study coordinator: Federico, Alexis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.